Heteroplasmy is defined by the presence of more than one type of mitochondrial DNA (mtDNA) within the cells of a single organism. This genetic state means an individual carries a mixed population of mitochondrial genomes, including both normal and mutated sequences. Understanding this cellular diversity is key to unraveling the complex inheritance patterns and variable severity seen in mitochondrial diseases. The ratio of these different mtDNA types determines whether a person remains healthy, experiences mild symptoms, or develops a severe disorder.
The Basics of Mitochondrial DNA
Mitochondria are organelles within human cells often described as the cell’s energy powerhouses, responsible for generating adenosine triphosphate (ATP), the primary energy currency. Unlike the main nuclear DNA, mitochondria contain their own small, circular DNA molecule, known as mtDNA. This mtDNA is inherited almost exclusively from the mother, meaning a child’s mtDNA sequence is identical to that of their mother. Every cell contains hundreds to thousands of mitochondria, and each mitochondrion can hold multiple copies of this small genome. The genes encoded by mtDNA are relatively few, but they are necessary for the creation of proteins involved in the energy-generating process of oxidative phosphorylation.
Understanding the Heteroplasmy Ratio
The concept of heteroplasmy contrasts with homoplasmy, where all copies of mtDNA within a cell or individual are genetically identical. The “heteroplasmy ratio” is a quantitative measure that expresses the percentage of mutant mtDNA copies relative to the total population of mtDNA in a given cell or tissue. This ratio is not static and can fluctuate significantly between different cells, tissues, and organs within the same individual. A person might have a low ratio of mutant mtDNA in a blood sample but a much higher ratio in a muscle biopsy, reflecting a mosaic distribution. The proportion of mutant mtDNA dictates the function of the individual mitochondria and the overall cellular health.
How Heteroplasmy Arises and is Inherited
Heteroplasmy can originate in two primary ways: through a new mutation occurring in a somatic cell or through inheritance from the mother. Somatic mutations occur spontaneously during an individual’s lifetime, often accumulating over time due to the high mutation rate of mtDNA and exposure to reactive oxygen species. These acquired mutations can lead to age-related conditions and are often seen in the development of certain cancers. Inherited heteroplasmy occurs when a mother passes the mixed population of mtDNA to her offspring.
The process is highly unpredictable due to a phenomenon called the “mitochondrial bottleneck.” During the formation of a mother’s egg cells, the number of mtDNA copies is dramatically reduced to a small, random subset of segregating units, estimated to be as few as 7 to 10 copies in humans. This severe bottleneck acts like a genetic lottery, causing the proportion of mutant mtDNA to shift randomly and drastically between the mother and her children, or even between siblings. A mother with a relatively low, asymptomatic heteroplasmy ratio might give birth to a child who, by chance, inherited a much higher ratio, leading to severe disease. The random partitioning of mitochondria during subsequent cell divisions further distributes this new ratio throughout the developing fetus.
The Clinical Impact of Varied Ratios
The most significant consequence of a varied heteroplasmy ratio is the “phenotypic threshold effect,” which describes the point at which the percentage of mutant mtDNA causes a biochemical defect and observable disease symptoms. Cells generally tolerate a high percentage of mutated mtDNA before dysfunction manifests. While this threshold varies depending on the specific mutation, it is often cited as being above 80% mutant mtDNA copies. Once the proportion of mutated mtDNA surpasses this threshold, the cell’s ability to produce sufficient energy through oxidative phosphorylation is compromised. Tissues that have the highest metabolic demands are the most sensitive to this energy deficit, meaning they have a lower functional threshold for a given mutation. This explains why mitochondrial diseases frequently affect the nervous system and muscle tissue, including the heart. A sibling may remain asymptomatic because their cells received a ratio below the disease threshold, while another sibling may develop a severe disorder because their ratio surpassed it.

